Core needle biopsy

PROCEDURE14 trials

Sponsors

Uppsala University, Rna Diagnostics Inc., Shandong Cancer Hospital and Institute, Dana-Farber Cancer Institute, Washington University School of Medicine

Conditions

Breast CancerBreast Neoplasm FemaleCancerCryobiopsy of Peripheral Lymph NodesDense BreastsEndocrine CancerNeuroendocrine (NE) TumorsNeuroendocrine Tumors

Phase 1

NeoVax With Nivolumab in Patients With Ovarian Cancer

Active, not recruitingNCT04024878

Dana-Farber Cancer InstituteOvarian Cancer

Start: 2020-11-20End: 2029-04-30Updated: 2025-06-18

Phase 2

RANKL Inhibition and Mammographic Breast Density

Active, not recruitingNCT04067726

Washington University School of MedicineDense Breasts

Start: 2019-08-27End: 2026-08-31Updated: 2026-03-31

Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Fudan UniversityThyroid Cancer

Start: 2019-06-01End: 2022-06-01Updated: 2021-04-01

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Fudan UniversityThyroid Cancer

Start: 2020-12-01End: 2023-12-31Target: 31Updated: 2020-11-03

A Study Comparing Two Types of Breast Lump Biopsy Methods in Women Receiving Care in Resource-Limited Hospitals

RecruitingPACTR202507578823215

Association of Radiation and Clinical Oncologists of NigeriaCancer

Start: 2025-02-03Target: 30Updated: 2026-01-27

Unknown Phase

Biomarker Study in Pancreatic Neuroendocrine Tumours

Uppsala UniversityNeuroendocrine Tumors

Start: 2017-05-01End: 2022-01-01Target: 30Updated: 2017-08-25

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

RecruitingNCT03524430

Rna Diagnostics Inc.Breast Neoplasm Female

Start: 2018-04-26End: 2031-03-31Target: 801Updated: 2025-10-14

Biomarker Study of Pancreatic Neuroendocrine Tumours

Uppsala UniversityPancreatic Neuroendocrine Tumor

Start: 2019-01-30End: 2024-12-31Target: 40Updated: 2022-05-18

Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer

Shandong Cancer Hospital and InstituteBreast Cancer

Start: 2017-06-01End: 2020-06-01Target: 50Updated: 2018-12-31

Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer

Shandong Cancer Hospital and InstituteBreast Cancer, Sentinel Lymph Node

Start: 2020-11-01End: 2021-06-01Target: 600Updated: 2020-10-27

Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

TerminatedNCT05435352

Ourotech, Inc.Triple Negative Breast Cancer, Triple Negative Breast Neoplasms

Start: 2022-06-06End: 2025-07-25Updated: 2025-07-30

Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy

San Antonio Uniformed Services Health Education ConsortiumCryobiopsy of Peripheral Lymph Nodes

Start: 2023-12-31End: 2025-12-31Target: 490Updated: 2023-11-07

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

RecruitingNCT06127979

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2023-11-06End: 2028-11-01Target: 42Updated: 2026-02-19

Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms

RecruitingNCT07121998

Uppsala UniversityEndocrine Cancer, Neuroendocrine (NE) Tumors

Start: 2025-03-01End: 2030-03-01Target: 94Updated: 2025-08-14

Related Papers

EXPLORING PERSONALISED GLIOBLASTOMA THERAPIES THROUGH FUNCTIONAL PRECISION MEDICINE: EARLY DATA FROM PEAR-GLIO

Neuro-Oncology2025-09-01

Abstract P3-01-18: Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC): Interim results from Cohort A

Clinical Cancer Research2025-06-13

Transforming kidney cancer treatment through AI-enabled functional precision medicine: The PEAR-TREE2 trial.

Journal of Clinical Oncology2025-05-28

PEAR-GLIO: Clinical evaluation of an AI-driven functional precision medicine platform for therapeutic efficacy in gliomas.

Journal of Clinical Oncology2025-05-28

The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Journal of Neuroendocrinology2025-05-054 citations

Abstract 3011: Novel CDK12 inhibitors with preclinical anti-tumor activity and best-in-class profile on HER2 low breast cancer patient samples

Cancer Research2025-04-21

Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC).

Journal of Clinical Oncology2024-05-29

Abstract 6767: Multivariate analysis of <i>ex vivo</i> kidney 3D immune-microtumors for functional precision medicine

Cancer Research2024-03-22

Abstract A083: Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer

Cancer Research2024-03-041 citations

Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer

JNCI Cancer Spectrum2023-12-192 citations

Development of a kidney cancer <i>ex vivo t</i>umor model and image-based artificial intelligence tool for precision immunotherapy and combination therapy testing.

Journal of Clinical Oncology2023-06-01

The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial

Thyroid2021-10-0668 citations

The efficacy and safety of anlotinib in neoadjuvant treatment in locally advanced thyroid cancer: A single-arm phase II clinical trial.

Journal of Clinical Oncology2021-05-208 citations